Reecha
An Important milestone for paediatric patients living with type-2 Diabetes
Farxiga (Dapagliflozin) now approved in US for paediatric patients with type 2 diabetes aged 10 years and older USFDA approved...
top of page
Reecha
- May 16
- 2 min
Advancement Revealed: Phase 3 Trial Results Unveil Once-Weekly Insulin Efsitora Alfa (Efsitora)
Eli Lilly has announced the positive results from QWINT-2 and QWINT-4 Phase 3 clinical trials. The trial evaluated once-weekly Efsitora...
37 views
Reecha
- Oct 4, 2023
- 2 min
News on SGLT2 inhibitor for diabetes management
T2NOW Phase III study results were presented at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)...
52 views
bottom of page